KIMBERLY MAJEROWICZ: Open Payments
NPI 1952182131 · DUNDALK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,810 in 105 payments from 21 companies in 2025. Trend: 2023 $179 · 2024 $1,427 · 2025 $1,810
Food & beverage: $1,810
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 14 | $263 |
| ABBVIE INC. | 25 | $231 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $209 |
| PFIZER INC. | 11 | $155 |
| AstraZeneca Pharmaceuticals LP | 7 | $139 |
| Novo Nordisk Inc | 7 | $137 |
| Dexcom, Inc. | 6 | $115 |
| E.R. Squibb & Sons, L.L.C. | 6 | $107 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $81 |
| Exact Sciences Corporation | 3 | $61 |
Products named: VRAYLAR, Kerendia, MOUNJARO, Dexcom G6 Transmitter, BREZTRI, NURTEC ODT, JARDIANCE, CAMZYOS.
Industry payments across MD — which companies pay providers there.
